These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 30395193

  • 21. Should expedited partner treatment for women with Trichomonas vaginalis be recommended?
    Kissinger P.
    Sex Transm Dis; 2010 Jun; 37(6):397-8. PubMed ID: 20453719
    [No Abstract] [Full Text] [Related]

  • 22. Intravenous metronidazole, liquid tinidazole, and intra-vaginal boric acid to cure trichomonas in a patient with gastric bypass surgery.
    Butt S, Tirmizi A.
    Int J STD AIDS; 2018 Jul; 29(8):825-827. PubMed ID: 29393008
    [Abstract] [Full Text] [Related]

  • 23. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA, El-Kholya EI, Abou El-Khair SM, Abdelmegeed ES, Hamoudaa MM, Mohamed SA, El-Tantawy NL.
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [Abstract] [Full Text] [Related]

  • 24. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.
    Helms DJ, Mosure DJ, Secor WE, Workowski KA.
    Am J Obstet Gynecol; 2008 Apr; 198(4):370.e1-7. PubMed ID: 18221927
    [Abstract] [Full Text] [Related]

  • 25. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD.
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [Abstract] [Full Text] [Related]

  • 26. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD, Nyirjesy P, Brown W.
    Clin Infect Dis; 2001 Oct 15; 33(8):1341-6. PubMed ID: 11565074
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Unexpected High Rates of Persistent Trichomonas vaginalis Infection in a Retrospective Cohort of Treated Pregnant Women.
    Lazenby GB, Thompson L, Powell AM, Soper DE.
    Sex Transm Dis; 2019 Jan 15; 46(1):2-8. PubMed ID: 30067546
    [Abstract] [Full Text] [Related]

  • 31. Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis?
    Thorley N, Ross J.
    Sex Transm Infect; 2018 Dec 15; 94(8):574-577. PubMed ID: 29223972
    [Abstract] [Full Text] [Related]

  • 32. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H, Yaman Karadam S, Malatyalı E, Ertuğ S.
    Mikrobiyol Bul; 2016 Oct 15; 50(4):552-558. PubMed ID: 28124960
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence and Risk Factors of Trichomonas vaginalis Among Female Sexual Workers in Nairobi, Kenya.
    Lockhart A, Senkomago V, Ting J, Chitwa M, Kimani J, Gakure H, Kwatampora J, Patel S, Mugo N, Smith JS.
    Sex Transm Dis; 2019 Jul 15; 46(7):458-464. PubMed ID: 31194717
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.